The present invention discloses a target specific cross-linked heteroantibody and a method
of producing the same. The cross-linked heteroantibodies of the present invention can
cause normal autologous cells of the immune system to destroy any unwanted cell for which
an antibody is available. Treatment or control of tumors, viral infected cells, fungi, bacteria,
parasites and the like is now made possible through the use of the heteroantibody complex
of the present invention.